MedPath

A study of non invasive evaluation of liver fibrosis in patients with Hepatitis B Virus(HBV) monoinfection using Fibroscan (Transient Elastography)

Not Applicable
Conditions
Hepatitis B Virus (HBV)
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12609000381280
Lead Sponsor
Alfred Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Chronic hepatitis B infection.
Subjects having a liver biopsy as part of routine standard of clinical care.
Body mass index < 36.

Exclusion Criteria

Co-infection with Human Immunodeficiency Virus(HIV), HepatitisC Virus(HCV), or Hepatitis D Virus (HDV).
Evidence of other causes of chronic liver disease.
Decompensated liver disease including ascites.
Evidence of alcohol abuse (> 20 gm/day) during the last 6 months.
Anticipated or current use or need for significant concomitant medical treatment including but not limited to systemic immunosuppressive drugs, cytotoxics, or chemotherapeutic agents.
History of recent acute hepatitis.
Clinical or radiological suspicion of Hepatocellular Carcinoma(HCC).
Presence of bleeding disorder.
Presence of cardiac pacemaker.
Contraindication to liver biopsy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath